β-Cells as a Cell Factory for On-Demand Recombinant Protein Dosing: Harnessing the Neuroendocrine Cell Secretory Pathway for Controlled Release
A. S. Y. Poon, J. Annes, E. A. Thomson, R. A. Lal, H. Xu, S. Lee
This paper develops a β-cell-based platform for on-demand recombinant protein delivery by modifying the endogenous insulin processing pathway to produce and release therapeutic peptides like GLP-1 or glucagon.
bioRxiv · Jan 20, 2024 · PreprintBioengineering